Healthcare Services US

US Biobanking Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

US Biobanking Market Industry Trends and Forecast to 2034: Segmented by (Sample, Service, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

US · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $1.42 Bn Placeholder estimate
Estimate 2025 $1.50 Bn 43% of the global market
Projected 2034 $2.48 Bn 64.7% Adds $973.0 Mn over 9 forecast years
CAGR 2025–2034 5.7% Faster than 32% of 107 Healthcare Services markets here
Key players 5
  • US is 42.98% of the global market.
  • In North America, the largest is US (this report) at $1.50 Bn.
  • Fastest growing: Canada at 8% a year.
  • US ranks 1st of 2 by size in North America.

Market size projection

US

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$973.0 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Biobanking Market market size by year, US
YearMarket sizeChange that yearSince 2025
2024 (estimate) $1.42 Bn — —
2025 (base) $1.50 Bn +$81.1 Mn —
2026 (forecast) $1.59 Bn +$85.7 Mn +5.7%
2027 (forecast) $1.68 Bn +$90.6 Mn +11.7%
2028 (forecast) $1.78 Bn +$95.8 Mn +18.1%
2029 (forecast) $1.88 Bn +$101.2 Mn +24.8%
2030 (forecast) $1.98 Bn +$107.0 Mn +31.9%
2031 (forecast) $2.10 Bn +$113.1 Mn +39.5%
2032 (forecast) $2.22 Bn +$119.6 Mn +47.4%
2033 (forecast) $2.34 Bn +$126.4 Mn +55.8%
2034 (forecast) $2.48 Bn +$133.6 Mn +64.7%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

US Biobanking Market Analysis at a glance
Market size, 2025$1.50 Bn placeholder estimate
Forecast, 2034$2.48 Bn placeholder estimate
Growth (CAGR), 2025–20345.7% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsSample, service and end user (see all)
Key playersThermo Fisher Scientific Inc., Azenta Life Sciences, Qiagen N.V., BioIVT, Hamilton Company (see all)
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The US Biobanking Market Analysis Executive Summary

Biobanking collects, stores and manages blood, tissue and DNA samples with health data for research.

Key segments of the biobanking market include sample (Blood, Tissue and DNA and RNA) and service (Storage, Processing and Data Management).

Bar chart: US Biobanking market size, 2024–2034, placeholder estimates. $1.42 Bn in 2024, $1.50 Bn in 2025 and $2.48 Bn in 2034, 5.7% CAGR.
US Biobanking market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

US Biobanking Market Dynamics

Market Growth Drivers

The falling cost of DNA sequencing, more targeted medicines, large national genome programmes and growing use of genetic results in everyday care are driving the biobanking market.

Opportunity

Routine use of genomics in screening, pharmacy and primary care gives the biobanking market large room to grow.

Market Restraints

Data privacy concerns, limited reimbursement for some tests, shortages of genetic counsellors and complex data analysis hold back the biobanking market.

Competitive Landscape for Biobanking Market in US

The biobanking market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Biobanking Market in US

Biobanking in the US: payment

Medicare covers people aged 65 and over and some younger people with disabilities, and Medicaid covers many people on low incomes; both are run with the Centers for Medicare & Medicaid Services (CMS).⁠[1]

Policy changes and Reimbursement scenario

Licensing, quality standards and payment models from public and private payers shape how biobanking services are delivered and paid for in US. Government health programs and insurance coverage are key to access.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Biobanking right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Biobanking in context

The US compared

  • Health spending per person: 13,473 US$ per person (2023). World: 1,317 US$ per person (2023).[1]
  • Doctors: 3.68 per 1,000 people (2022). World: 1.86 per 1,000 people (2022).[2]
  • People aged 65 and over: 18.4% of people (2025). World: 10.4% of people (2025).[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 16 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 17 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 17 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Biobanking market in the US?
Placeholder estimate: about $1.50 Bn in 2025, rising to about $2.48 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Biobanking market in the US growing?
Placeholder estimate: about 5.7% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Biobanking market report cover?
The report splits the market by sample (Blood, Tissue, DNA and RNA, Cells), service (Storage, Processing, Data Management) and end user (Hospitals, Clinics, Home Care, Corporate and Payer Clients).
Who are the key players in the Biobanking market?
Key players include Thermo Fisher Scientific Inc., Azenta Life Sciences, Qiagen N.V., BioIVT and Hamilton Company.
What is driving the Biobanking market?
The falling cost of DNA sequencing, more targeted medicines, large national genome programmes and growing use of genetic results in everyday care are driving the biobanking market.
How is healthcare paid for in the US?
Medicare covers people aged 65 and over and some younger people with disabilities, and Medicaid covers many people on low incomes; both are run with the Centers for Medicare & Medicaid Services (CMS). Source: Centers for Medicare & Medicaid Services. Checked 14 Nov 2026.
How much research is published on Biobanking?
PubMed lists 1,325 papers on Biobanking added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Healthcare Services reports in US

See all

Related on genomics

See the topic